Brinker Capital Investments’s Core Laboratories CLB Stock Holding History

Brinker Capital Investments’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,692	Closed	-$212K	–	1358
2022 Q1	$212K	Buy	+6,692	New	+$188K	﹤0.01%	1330
2021 Q4	–	Sell	-7,631	Closed	-$297K	–	1382
2021 Q3	$297K	Hold	7,631	–	–	﹤0.01%	1142
2021 Q2	$297K	Sell	7,631 -24	-0.3%	-$860	﹤0.01%	1194
2021 Q1	$220K	Buy	+7,655	New	+$262K	﹤0.01%	1133

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brinker Capital Investments's CLB Position: Q2 2022 in Review

Brinker Capital Investments sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 6,692 shares — an estimated $212K sold.

Brinker Capital Investments first reported a position in CLB in Q1 2021 and held it in 4 quarters. The position peaked at $297K in Q3 2021. 176 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

Brinker Capital Investments reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
Brinker Capital Investments sold 6,692 Core Laboratories shares in Q2 2022, an estimated $212K.
Brinker Capital Investments first reported a position in Core Laboratories in Q1 2021 and held it in 4 quarters.
Brinker Capital Investments's Core Laboratories position peaked at $297K in Q3 2021.
176 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Brinker Capital Investments's 13F filing for Q2 2022, filed 18 Jul 2022.